July 6, 2015
Mesothelioma specialists at the Pacific Mesothelioma Center (PMC), David Geffen School of Medicine UCLA, have long been advocates for using cryoablation to treat mesothelioma tumors that return following surgery. Now PMC researchers reportedly are looking for ways to boost the effectiveness of cryoablation with immunotherapy.
PMC surgeon Dr. Robert B. Cameron treats mesothelioma patients with a surgical procedure that preserves the lung while removing as much cancer as possible. The procedure — known as Pleurectomy/Decortication, or P/D — differs dramatically from the extrapleural pneumonectomy (EPP) surgery in which other mesothelioma doctors remove the entire affected lung. Retaining the lung gives patients a better quality of life following surgery, the PMC team believes.
During surgery, mesothelioma patients may be treated with an interleukin 4 (IL-4) toxin that is effective at targeting remaining cancer cells. After surgery, mesothelioma patients receive an innovative form of radiation therapy that precisely aims high doses of ionizing radiation at the site of the mesothelioma tumor.
Unfortunately, no alternative provides an absolute cure for mesothelioma. When the tumor returns, UCLA doctors rely on cryoablation to slow the cancer’s regrowth. Cryoablation kills mesothelioma cells by freezing them. Doctors use a needle to apply compressed argon gas to any cancerous cells. The outpatient procedure can be done in four hours and usually causes few side effects.
PMC doctors are now involved in research to learn whether cryoablation works even better in combination with immunotherapy.
If you (or a loved one) have been diagnosed with mesothelioma, contact us by email or call us at 800.226.9880 to speak with our mesothelioma lawyers, like Michael Gurien in our Los Angeles office, to learn more about how we can assist you and your family with a mesothelioma lawsuit.
Our Results
Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.
Confidential settlement for the wife of a Rhode Island man who died of mesothelioma cancer after exposure to window glazing compound contaminated with asbestos.
That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus Paul & Siegel has what it takes to fight against big corporate interests and win. That’s why we’ve recovered more than $1.3 billion for clients like you.
